SK Biopharmaceuticals Co., Ltd.

KRX:326030.KS

114400 (KRW) • At close November 1, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

2023202220212020201920182017201620152014201320122011
Omzet 354,891.556246,179.12418,644.52925,999.027123,852.4161,098.73885,316.0789,927.54571,416.70272,440.82160,454.79151,798.06337,631.486
Kosten van de omzet 46,517.09437,768.13422,335.9941,974.01514.1973,342.29981,744.54378,853.3645,692.0746,580.3644,396.37737,670.62327,398.834
Brutowinst 308,374.461208,410.986396,308.53524,025.016123,338.219-2,243.5613,571.52711,074.18525,724.63125,860.46116,058.41414,127.4410,232.652
Brutowinstmarge 0.8690.8470.9470.9240.996-2.0420.0420.1230.360.3570.2660.2730.272
Onderzoek- en ontwikkelingskosten 137,126.137122,816.743114,526.335108,441.385176,212.762121,288.48985,597.81953,544.92556,617.4454,388.24649,794.52535,066.06322,929.322
Algemene en administratieve kosten 61,726.56262,435.42449,961.65853,734.9969,067.8028,944.0783,889.4483,078.6243,721.5541,964.1082,163.2662,758.5372,669.299
Verkoop- en marketingkosten 40,141.87249,886.08739,839.60225,360.834488.735227.028875.9321,246.4611,291.799866.3241,070.8371,057.721753.521
Verkoop-, algemene en administratieve kosten 204,312.85112,321.51189,801.2679,095.839,556.5379,171.1064,765.384,325.0855,013.3532,830.4323,234.1033,816.2583,422.82
Overige kosten -4,457.671104,350.76197,022.73975,986.62516,827.657380.485-157.553-277.76382.992-249.022-1,161.201899.5114,321.476
Bedrijfskosten 345,896.658339,489.015301,350.334263,523.84202,596.956140,202.046101,544.93568,747.70765,167.51465,098.87460,216.36250,117.67730,673.618
Bedrijfsresultaat -37,522.197-131,078.02974,247.722-239,498.824-79,258.737-139,103.308-97,973.408-57,673.521-39,442.882-39,238.413-44,157.947-35,990.237-24,307.863
Bedrijfsresultaat ratio -0.106-0.5320.177-9.212-0.64-126.603-1.148-0.641-0.552-0.542-0.73-0.695-0.646
Totaal overige inkomsten en kosten netto 5,199.09-11,390.835-2,971.174-410.506-5,192.3331,464.5371,163.9327,312.67913,655.3213,000.0981,604.5926,033.543-249.297
Inkomen voor belasting -32,323.107-142,468.86471,276.548-239,909.329-84,451.069-137,638.771-96,809.478-30,360.843-25,787.562-36,238.315-42,553.356-29,956.694-20,690.263
Inkomen voor belasting ratio -0.091-0.5790.17-9.228-0.682-125.27-1.135-0.338-0.361-0.5-0.704-0.578-0.55
Belastingkosten -8,478.274-3,037.9866,430.9087,504.284-12,931.602583.199839.58128,348.7362,273.625810.561-1,551.442373.904-1,225.126
Nettowinst -32,882.849-139,430.87864,845.64-247,413.614-71,519.467-138,096.479-97,649.06-30,360.843-28,061.186-37,048.875-41,001.914-30,330.598-19,465.137
Nettowinstmarge -0.093-0.5660.155-9.516-0.577-125.686-1.145-0.338-0.393-0.511-0.678-0.586-0.517
WPA (Winst Per Aandeel) -419.89-1,780.43828.03-3,447.52-3,652.99-2,219-1,953-607-561.25-749-1,025-758-487
Verwaterde WPA -419.89-1,780.43828.03-3,447.52-3,652.99-2,219-1,953-607-561.25-749-1,025-758-487
EBITDA -22,204.753-113,113.72285,889.55-226,533.389-73,981.942-133,841.23-93,569.686-26,239.702-31,563.02-31,124.016-37,420.991-22,548.7-11,061.079
EBITDA ratio -0.063-0.4590.205-8.713-0.597-121.814-1.097-0.292-0.442-0.43-0.619-0.435-0.294